跳至主要内容
临床试验/NCT04612881
NCT04612881Unknown不适用

Clinical Verification of the Activity and Tolerability of Fitostimoline Vaginal Pessaries in Women With Hysterectomy. Randomized, Perspective, Monoscentric Study.

University of Milan1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年10月18日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
60
试验地点
1
主要终点
TSS

研究概览

简要总结

Clinical evaluation of Fitostimoline vaginal pessaries in the treatment of hysterectomy. An observational, randomized, perspective study performed on 60 women where 30 women are treated with fitostimoline pessaries and 30 women are treated with the standard of care.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
30 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • patient aged between 35 and 80 years
  • patient undergoing hysterectomy
  • Willingness to understand the procedures and aims of the study

排除标准

  • Anamnestic or clinical data of metabolic or endocrine diseases (such as uncontrolled diabetes mellitus) or any other local and / or systemic pathology potentially able to interfere with the study parameters;
  • Concomitant treatment with antibiotics / antiseptics, NSAIDs, analgesics (excl. Paracetamol)
  • Non-therapeutic use of psychoactive substances;
  • Abuse of drugs and / or alcohol / smoking;
  • Neurological disorders or psychiatric conditions potentially capable of affecting the validity of the consent and / or compromising the patient's adherence to the study procedures;
  • Known allergy, hypersensitivity or intolerance to the constituents of the preparations under study;
  • Any condition, medical or otherwise, that could significantly reduce the possibility of obtaining reliable data, achieving the objectives of the study, perfecting its completion;
  • Presumption of poor reliability or collaboration;
  • Treatment with any preparation in the last 30 days prior to the start of the study;
  • Patients already enrolled in this study;
  • Center staff directly involved in the study and close relatives

研究组 & 干预措施

fitostimoline vaginal pessaries

干预措施: fitostimoline vaginal pessaries (Drug)

fitostimoline vaginal pessaries

干预措施: standard of care (Other)

结局指标

主要结局

TSS

时间窗: 60 days

total symptom score (TSS) on a scale from 0 to 10 from worst to best

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michele Vignali

PROFESSOR

University of Milan

研究点 (1)

Loading locations...

相似试验